Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions
Main Author: | |
---|---|
Publication Date: | 2003 |
Other Authors: | , |
Format: | Article |
Language: | eng |
Source: | São Paulo medical journal (Online) |
Download full: | https://periodicosapm.emnuvens.com.br/spmj/article/view/2655 |
Summary: | CONTEXT: Proton spectroscopy has been recognized as a safe and noninvasive diagnostic method that, coupled with magnetic resonance imaging techniques, allows for the correlation of anatomical and physiological changes in the metabolic and biochemical processes occurring within previouslydetermined volumes in the brain. There are two methods of proton magnetic resonance spectroscopy: single voxel and chemical shift imaging OBJECTIVE: The present work focused on the clinical applications of proton magnetic resonance spectroscopy in patients with brain lesions. CONCLUSIONS: In vivo proton spectroscopy allows the detection of certain metabolites in brain tissue, such as N-acetyl aspartate, creatine, choline, myoinositol, amino acids and lipids, among others. N-acetyl aspartate is a neuronal marker and, as such, its concentration will decrease in the presence of aggression to the brain. Choline increase is the main indicator of neoplastic diseases. Myoinositol is raised in patients with Alzheimer’s disease. Amino acids are encountered in brain abscesses. The presence of lipids is related to necrotic processes. |
id |
APM-1_d4bd87bfbddf39a1cbb2f6eddae1753e |
---|---|
oai_identifier_str |
oai:ojs.diagnosticoetratamento.emnuvens.com.br:article/2655 |
network_acronym_str |
APM-1 |
network_name_str |
São Paulo medical journal (Online) |
repository_id_str |
|
spelling |
Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesionsEspectroscopia de prótons por ressonância magnética: aplicações clínicas em pacientes com lesões encefálicasEspectroscopia de prótonsRessonância magnéticaEncéfaloProtonSpectroscopyMagnetic resonanceBrainCONTEXT: Proton spectroscopy has been recognized as a safe and noninvasive diagnostic method that, coupled with magnetic resonance imaging techniques, allows for the correlation of anatomical and physiological changes in the metabolic and biochemical processes occurring within previouslydetermined volumes in the brain. There are two methods of proton magnetic resonance spectroscopy: single voxel and chemical shift imaging OBJECTIVE: The present work focused on the clinical applications of proton magnetic resonance spectroscopy in patients with brain lesions. CONCLUSIONS: In vivo proton spectroscopy allows the detection of certain metabolites in brain tissue, such as N-acetyl aspartate, creatine, choline, myoinositol, amino acids and lipids, among others. N-acetyl aspartate is a neuronal marker and, as such, its concentration will decrease in the presence of aggression to the brain. Choline increase is the main indicator of neoplastic diseases. Myoinositol is raised in patients with Alzheimer’s disease. Amino acids are encountered in brain abscesses. The presence of lipids is related to necrotic processes.CONTEXTO: A espectroscopia de prótons é reconhecidamente um método não invasivo que, quando associada à imagem por ressonância magnética, possibilita a correlação de alterações metabólicas e bioquímicas com mudanças fisiológicas e anatômicas dentro de um volume previamente determinado no encéfalo. Existem dois métodos de espectroscopia de prótons por ressonância magnética: volume único de interesse (single voxel) e imagem espectroscópica (chemical shift imaging). OBJETIVO: Este trabalho discute as aplicações clínicas da espectroscopia de prótons por ressonância magnética em pacientes com lesões encefálicas. CONCLUSÕES: A espectroscopia de próton por ressonância magnética in vivo permite detectar alguns metabólitos existentes no tecido encefálico, como N-acetil aspartato, creatina, colina, mio-inositol, aminoácidos, lipídios, entre outros. O N-acetil aspartato é um marcador neuronal cuja concentração diminui quando há lesão encefálica. O aumento na concentração de colina é o principal indicador de doenças neoplásicas. A quantidade de mio-inositol apresenta-se aumentada em casos de doença de Alzheimer. Aminoácidos estão presentes em abscessos encefálicos. A presença de lipídios está relacionada à necrose tecidual.São Paulo Medical JournalSão Paulo Medical Journal2003-11-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicosapm.emnuvens.com.br/spmj/article/view/2655São Paulo Medical Journal; Vol. 121 No. 6 (2003); 254-259São Paulo Medical Journal; v. 121 n. 6 (2003); 254-2591806-9460reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APMenghttps://periodicosapm.emnuvens.com.br/spmj/article/view/2655/2542https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRamin, Sérgio LuizTognola, Waldir AntônioSpotti, Antonio Ronaldo2023-10-09T14:15:45Zoai:ojs.diagnosticoetratamento.emnuvens.com.br:article/2655Revistahttp://www.scielo.br/spmjPUBhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2023-10-09T14:15:45São Paulo medical journal (Online) - Associação Paulista de Medicinafalse |
dc.title.none.fl_str_mv |
Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions Espectroscopia de prótons por ressonância magnética: aplicações clínicas em pacientes com lesões encefálicas |
title |
Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions |
spellingShingle |
Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions Ramin, Sérgio Luiz Espectroscopia de prótons Ressonância magnética Encéfalo Proton Spectroscopy Magnetic resonance Brain |
title_short |
Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions |
title_full |
Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions |
title_fullStr |
Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions |
title_full_unstemmed |
Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions |
title_sort |
Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions |
author |
Ramin, Sérgio Luiz |
author_facet |
Ramin, Sérgio Luiz Tognola, Waldir Antônio Spotti, Antonio Ronaldo |
author_role |
author |
author2 |
Tognola, Waldir Antônio Spotti, Antonio Ronaldo |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Ramin, Sérgio Luiz Tognola, Waldir Antônio Spotti, Antonio Ronaldo |
dc.subject.por.fl_str_mv |
Espectroscopia de prótons Ressonância magnética Encéfalo Proton Spectroscopy Magnetic resonance Brain |
topic |
Espectroscopia de prótons Ressonância magnética Encéfalo Proton Spectroscopy Magnetic resonance Brain |
description |
CONTEXT: Proton spectroscopy has been recognized as a safe and noninvasive diagnostic method that, coupled with magnetic resonance imaging techniques, allows for the correlation of anatomical and physiological changes in the metabolic and biochemical processes occurring within previouslydetermined volumes in the brain. There are two methods of proton magnetic resonance spectroscopy: single voxel and chemical shift imaging OBJECTIVE: The present work focused on the clinical applications of proton magnetic resonance spectroscopy in patients with brain lesions. CONCLUSIONS: In vivo proton spectroscopy allows the detection of certain metabolites in brain tissue, such as N-acetyl aspartate, creatine, choline, myoinositol, amino acids and lipids, among others. N-acetyl aspartate is a neuronal marker and, as such, its concentration will decrease in the presence of aggression to the brain. Choline increase is the main indicator of neoplastic diseases. Myoinositol is raised in patients with Alzheimer’s disease. Amino acids are encountered in brain abscesses. The presence of lipids is related to necrotic processes. |
publishDate |
2003 |
dc.date.none.fl_str_mv |
2003-11-11 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicosapm.emnuvens.com.br/spmj/article/view/2655 |
url |
https://periodicosapm.emnuvens.com.br/spmj/article/view/2655 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://periodicosapm.emnuvens.com.br/spmj/article/view/2655/2542 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
São Paulo Medical Journal São Paulo Medical Journal |
publisher.none.fl_str_mv |
São Paulo Medical Journal São Paulo Medical Journal |
dc.source.none.fl_str_mv |
São Paulo Medical Journal; Vol. 121 No. 6 (2003); 254-259 São Paulo Medical Journal; v. 121 n. 6 (2003); 254-259 1806-9460 reponame:São Paulo medical journal (Online) instname:Associação Paulista de Medicina instacron:APM |
instname_str |
Associação Paulista de Medicina |
instacron_str |
APM |
institution |
APM |
reponame_str |
São Paulo medical journal (Online) |
collection |
São Paulo medical journal (Online) |
repository.name.fl_str_mv |
São Paulo medical journal (Online) - Associação Paulista de Medicina |
repository.mail.fl_str_mv |
revistas@apm.org.br |
_version_ |
1825135077753880576 |